Zacks Investment Research on MSN
ImmunityBio rises on China nod to bladder cancer combo therapy
Shares of ImmunityBio IBRX were up 11% on Monday after the company announced that Macau’s regulatory body has approved its ...
Democratic governors across the US are facing pressure on whether to back President Donald Trump’s controversial new federal ...
With the approval of Wegovy HD, Novo Nordisk joins Johnson & Johnson, Boehringer Ingelheim and USAntibiotics as beneficiaries ...
Entering the 2025–26 NBA season, it was clear the Dallas Mavericks planned to use Cooper Flagg in a variety of roles. One of those roles was at point guard, an ambitious and challenging assignment for ...
Alfasigma’s buzzer-beater bet on GSK’s rare liver disease prospect has paid off. | Lynavoy is now the first FDA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results